Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (8565)	5/26/1998 7:34:00 PM
From: DaiS	Read Replies (1) \| Respond to of 23519

Vlad, OK, it's more complex than I thought. I was just trying to work out how analysts' EPS estimates of about 0.3 for this year square with the drop in sales caused by viagra. I thought the EPS estimates seemed low given that UK sales should be included. Also I am puzzled that the EPS growth rate estimates of 25% seem low given that all these new countries are coming in soon - even taking account that they will get viagra too. But is it that we are dealing here with a constraint on the extent to which Vivus can expand production? DaiS I got my info from marketguide.com